Evidence map›Paper›PMID 29306975›Full record

ArticleLasers in medical science2018

Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer.

Liming Liang, Wenxiang Bi, Weiwen Chen, Yani Lin, Yuanyuan Tian

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Recent developments in translational imaging of in vivo gene therapy outcomes.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Liming LiangDepartment of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China.
Wenxiang BiDepartment of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China.
Weiwen ChenDepartment of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China.
Yani LinDepartment of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China.
Yuanyuan TianDepartment of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, 250012, China. tianyuan@sdu.edu.cn.
Shandong University · CN

Funding

National Natural Science Foundation of China 81372764National Natural Science Foundation of China 81401495
6 · The paper itself

Abstract

We combined pyropheophorbide-a methyl ester, photodynamic therapy (MPPa-PDT), 670 ± 10 nm, 4 mW/cm

Indexed as

Genetic TherapyPhotochemotherapyAnimalsApoptosisCell Line, TumorCell SurvivalCombined Modality TherapyEndoplasmic Reticulum Chaperone BiPFatty AcidsGanciclovirHerpesvirus 1, HumanHumansMaleProstatic NeoplasmsThymidine KinaseTransfection15-phenyl-beta-methylpentadecanoic acidEndoplasmic Reticulum Chaperone BiPFatty AcidsGanciclovirHSPA5 protein, humanThymidine KinaseGRP78 promoterHSV1-TKMPPaPDTProstate cancer

Identifiers

PMID29306975
OpenAlexW2781875409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.